GlassScriptPhysician profile
Soraya A Breda
NPI 1174556260
$3,969.40
in general payments reported to CMS, 2019-2025
24 companies · $1,192 in 2025
The $1,192 reported for 2025 was more than what 86% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $376 · 2022: $322 · 2023: $932 · 2024: $1,147 · 2025: $1,192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,121.72 |
| Education | $149.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $651.76 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $541.27 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $398.50 | 2024-2025 | Dupixent |
| Leo Pharma INC. | $349.44 | 2021-2025 | Adbry |
| Incyte Corporation | $347.00 | 2021-2024 | Opzelura |
| Amgen INC. | $305.26 | 2022-2024 | Otezla |
| Abbvie INC. | $257.19 | 2021-2025 | |
| Galderma Laboratories, L.P. | $213.90 | 2021-2025 | Aklief, Nemluvio |
| Novartis Pharmaceuticals Corporation | $116.22 | 2024-2025 | |
| Dermavant Sciences, INC. | $106.04 | 2024 | Vtama |
| Merz North America, INC. | $86.07 | 2021-2022 | |
| Almirall LLC | $80.36 | 2021-2025 | Seysara |
| Sun Pharmaceutical Industries INC. | $79.44 | 2021-2023 | Absorica Ld, Winlevi, Ilumya |
| Pfizer INC. | $77.06 | 2021-2023 | |
| Lilly USA, LLC | $72.81 | 2021-2025 | Taltz |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $67.88 | 2025 | Vtama |
| Biofrontera INC. | $56.11 | 2021-2024 | Xepi, Bf-Rhodoled, Ameluz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.33 | 2023-2025 | Jublia, Cabtreo, Duobrii |
| Janssen Biotech, INC. | $42.05 | 2021-2024 | Tremfya |
| Vyne Pharmaceuticals INC. | $20.13 | 2021 | |
| Botanix Sb INC | $19.17 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $17.69 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $13.49 | 2022 | |
| Mayne Pharma Commercial LLC | $7.23 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soraya Breda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.